4
Stories per week
1
Expert Writer
57,000
Subscribers
Weekly
Frequency

Professional Audience
A mix of industry and academic researchers who lead much of this work along with the large contingent of biotech executives and venture players looking to invest in next-gen therapies. 

Content Focus
New companies, therapies and technologies, government funding for preclinical research, NIH grants, early-stage biotech work, animal studies and alternative funding mechanisms for drug research.

Reader Demographics

Pharmaceutical - 26%
Biotech - 21%
Other - 18%
Consultant - 9%
Contract Research Organization - 6%
Medical - 5%
Medical Devices & Diagnostics - 3%
Advertising/Marketing/Public Relations - 2%
Contract Manufacturing Organization - 2%
Life Sciences IT - 2%
Government - 1%
Financial - 1%
Chemicals - 1%
Lab Services/Analysis/CSO - 1%
Instrumentation - 1%
Clinical Trials - 1%

Staff - 22%
Manager - 21%
Director - 18%
C-Level - 18%
Pres/VP/SVP/EVP - 10%

Other - 13%
Laboratory/R&D - 13%
Marketing & Brand Management - 12%
Executive Management - 12%
Operations - 10%
Consultant - 7%
Pharmacovigilence/Regulatory - 6%
Clinical Operations - 6%
Clinical/Preclinical Research - 5%
Finance - 4%
Business Development - 4%
Facility Design/Production - 2%
Supply/Purchasing/Sourcing/Outsourcing Mgmt - 2%
Project Management - 2%
Medical Affairs/Writing - 2%
Purchasing/Procurement/Acquisitions - 1%
Engineering - 1%
Packaging/Logistics/Distribution - 1%

North America - 68%
Asia Pacific - 14%
Europe - 14%
Other - 4%